NCT03480360 2026-02-19Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' ExpressionDartmouth-Hitchcock Medical CenterPhase 3 Active not recruiting21 enrolled 19 charts
NCT04576156 2025-12-04A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor TreatmentGeron CorporationPhase 3 Active not recruiting327 enrolled